1. Home
  2. BATRK vs ARQT Comparison

BATRK vs ARQT Comparison

Compare BATRK & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BATRK
  • ARQT
  • Stock Information
  • Founded
  • BATRK 1991
  • ARQT 2016
  • Country
  • BATRK United States
  • ARQT United States
  • Employees
  • BATRK N/A
  • ARQT N/A
  • Industry
  • BATRK Broadcasting
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • BATRK Industrials
  • ARQT Health Care
  • Exchange
  • BATRK Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • BATRK 2.5B
  • ARQT 2.1B
  • IPO Year
  • BATRK N/A
  • ARQT 2020
  • Fundamental
  • Price
  • BATRK $38.60
  • ARQT $25.15
  • Analyst Decision
  • BATRK Strong Buy
  • ARQT Strong Buy
  • Analyst Count
  • BATRK 3
  • ARQT 7
  • Target Price
  • BATRK $58.00
  • ARQT $22.17
  • AVG Volume (30 Days)
  • BATRK 338.6K
  • ARQT 2.8M
  • Earning Date
  • BATRK 11-05-2025
  • ARQT 10-28-2025
  • Dividend Yield
  • BATRK N/A
  • ARQT N/A
  • EPS Growth
  • BATRK N/A
  • ARQT N/A
  • EPS
  • BATRK N/A
  • ARQT N/A
  • Revenue
  • BATRK $723,307,000.00
  • ARQT $317,929,000.00
  • Revenue This Year
  • BATRK $14.16
  • ARQT $85.27
  • Revenue Next Year
  • BATRK $3.97
  • ARQT $30.70
  • P/E Ratio
  • BATRK N/A
  • ARQT N/A
  • Revenue Growth
  • BATRK 6.62
  • ARQT 129.21
  • 52 Week Low
  • BATRK $35.46
  • ARQT $8.90
  • 52 Week High
  • BATRK $47.18
  • ARQT $27.08
  • Technical
  • Relative Strength Index (RSI)
  • BATRK 36.61
  • ARQT 62.46
  • Support Level
  • BATRK $38.29
  • ARQT $23.32
  • Resistance Level
  • BATRK $39.64
  • ARQT $24.39
  • Average True Range (ATR)
  • BATRK 1.02
  • ARQT 1.63
  • MACD
  • BATRK -0.06
  • ARQT -0.15
  • Stochastic Oscillator
  • BATRK 16.08
  • ARQT 62.80

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: